全文获取类型
收费全文 | 10271篇 |
免费 | 910篇 |
国内免费 | 546篇 |
专业分类
耳鼻咽喉 | 144篇 |
儿科学 | 55篇 |
妇产科学 | 39篇 |
基础医学 | 902篇 |
口腔科学 | 77篇 |
临床医学 | 899篇 |
内科学 | 1171篇 |
皮肤病学 | 76篇 |
神经病学 | 1148篇 |
特种医学 | 94篇 |
外科学 | 285篇 |
综合类 | 1427篇 |
现状与发展 | 3篇 |
一般理论 | 2篇 |
预防医学 | 524篇 |
眼科学 | 56篇 |
药学 | 2543篇 |
4篇 | |
中国医学 | 2115篇 |
肿瘤学 | 163篇 |
出版年
2024年 | 37篇 |
2023年 | 194篇 |
2022年 | 305篇 |
2021年 | 440篇 |
2020年 | 387篇 |
2019年 | 299篇 |
2018年 | 321篇 |
2017年 | 286篇 |
2016年 | 300篇 |
2015年 | 324篇 |
2014年 | 500篇 |
2013年 | 695篇 |
2012年 | 469篇 |
2011年 | 538篇 |
2010年 | 444篇 |
2009年 | 423篇 |
2008年 | 428篇 |
2007年 | 471篇 |
2006年 | 407篇 |
2005年 | 364篇 |
2004年 | 303篇 |
2003年 | 307篇 |
2002年 | 283篇 |
2001年 | 273篇 |
2000年 | 241篇 |
1999年 | 205篇 |
1998年 | 170篇 |
1997年 | 173篇 |
1996年 | 177篇 |
1995年 | 164篇 |
1994年 | 178篇 |
1993年 | 125篇 |
1992年 | 112篇 |
1991年 | 118篇 |
1990年 | 128篇 |
1989年 | 95篇 |
1988年 | 83篇 |
1987年 | 91篇 |
1986年 | 75篇 |
1985年 | 108篇 |
1984年 | 97篇 |
1983年 | 74篇 |
1982年 | 79篇 |
1981年 | 81篇 |
1980年 | 62篇 |
1979年 | 50篇 |
1978年 | 39篇 |
1977年 | 43篇 |
1976年 | 49篇 |
1974年 | 35篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
目的:采用非标记定量(Label-free)蛋白质组学技术研究色胺酮抗小鼠体内乳腺癌的作用机制。方法:采用超高效液相色谱-质谱联用技术检测色胺酮抗小鼠乳腺癌的表达蛋白,选择Ionoptics nano UPLC C18色谱柱(0.075 mm×250 mm,1.6μm),流动相0.1%甲酸水溶液-0.1%甲酸乙腈溶液梯度洗脱,正离子模式,扫描范围m/z 100~1 700,使用MaxQuant 1.6.5.0进行数据库检索。采用Label-free高分辨质谱的蛋白质组学技术筛选4T1乳腺癌小鼠模型组与色胺酮(100 mg·kg~(-1))口服给药组之间的差异表达蛋白,进行色胺酮抗乳腺癌的蛋白质组学研究。结果:共鉴定出3 997个蛋白质,其中有2 911个蛋白可定量。模型组与色胺酮组共750个差异表达蛋白,其中286个蛋白上调,464个蛋白下调。基因本体分析表明,这些差异表达蛋白主要参与增殖、细胞迁移、凋亡、免疫、血管生成和炎症调节等生物学过程。京都基因与基因组百科全书通路分析进一步表明,这些蛋白主要集中于T细胞受体,B细胞受体,Toll样受体,核转录因子-κB(NF-κB),Ras蛋白,白细胞介素-17,肿瘤坏死因子,磷脂酰肌醇3-激酶/蛋白激酶B(PI3K-Akt)和丝裂原活化蛋白激酶(MAPK)等信号通路。结论:与色胺酮抗4T1乳腺癌作用密切相关的差异表达蛋白包括上调蛋白白细胞分化抗原14(CD14),前列腺素G/H合酶2(PTGS2),泛素蛋白连接酶E3和下调蛋白CD44,70 kDa热休克蛋白1A(HSPA1A),巨噬细胞移动抑制因子(MIF),NF-κB,核糖体蛋白S6激酶α-4(RPS6KA4)和高迁移率族蛋白B1(HMGB1),提示色胺酮主要通过调节肿瘤炎症微环境来达到抑制小鼠乳腺癌的作用。 相似文献
22.
23.
Stephen D. Dertinger Andrew R. Kraynak Ryan P. Wheeldon Derek T. Bernacki Steven M. Bryce Nikki Hall Jeffrey C. Bemis Sheila M. Galloway Patricia A. Escobar George E. Johnson 《Environmental and molecular mutagenesis》2019,60(6):513-533
The in vitro MultiFlow® DNA Damage Assay multiplexes γH2AX, p53, phospho-histone H3, and polyploidization biomarkers into a single flow cytometric analysis. The current report describes a tiered sequential data analysis strategy based on data generated from exposure of human TK6 cells to a previously described 85 chemical training set and a new pharmaceutical-centric test set (n = 40). In each case, exposure was continuous over a range of closely spaced concentrations, and cell aliquots were removed for analysis following 4 and 24 hr of treatment. The first data analysis step focused on chemicals' genotoxic potential, and for this purpose, we evaluated the performance of a machine learning (ML) ensemble, a rubric that considered fold increases in biomarkers against global evaluation factors (GEFs), and a hybrid strategy that considered ML and GEFs. This first tier further used ML output and/or GEFs to classify genotoxic activity as clastogenic and/or aneugenic. Test set results demonstrated the generalizability of the first tier, with particularly good performance from the ML ensemble: 35/40 (88%) concordance with a priori genotoxicity expectations and 21/24 (88%) agreement with expected mode of action (MoA). A second tier applied unsupervised hierarchical clustering to the biomarker response data, and these analyses were found to group certain chemicals, especially aneugens, according to their molecular targets. Finally, a third tier utilized benchmark dose analyses and MultiFlow biomarker responses to rank genotoxic potency. The relevance of these rankings is supported by the strong agreement found between benchmark dose values derived from MultiFlow biomarkers compared to those generated from parallel in vitro micronucleus analyses. Collectively, the results suggest that a tiered MultiFlow data analysis pipeline is capable of rapidly and effectively identifying genotoxic hazards while providing additional information that is useful for modern risk assessments—MoA, molecular targets, and potency. Environ. Mol. Mutagen. 60:513–533, 2019. © 2019 Wiley Periodicals, Inc. 相似文献
24.
《Clinical neurophysiology》2019,130(4):573-581
ObjectiveWe describe a stimulus-evoked EMG approach to minimize false negative results in detecting pedicle breaches during lumbosacral spinal instrumentation.MethodsIn 36 patients receiving 176 lumbosacral pedicle screws, EMG threshold to nerve root activation was determined using a focal probe inserted into the pilot hole at a depth, customized to the individual patients, suitable to position the stimulating tip at the point closest to the tested nerve root. Threshold to screw stimulation was also determined.ResultsMean EMG thresholds in 161 correctly fashioned pedicle instrumentations were 7.5 mA ± 2.46 after focal hole stimulation and 21.8 mA ± 6.8 after screw stimulation. Direct comparison between both thresholds in individual pedicles showed that screw stimulation was always biased by an unpredictable leakage of the stimulating current ranging from 10 to 90%. False negative results were never observed with hole stimulation but this was not true with screw stimulation.ConclusionsFocal hole stimulation, unlike screw stimulation, approaches absolute EMG threshold as shown by the lower normal limit (2.6 mA; p < 0.05) that borders the upper limit of threshold to direct activation of the exposed root.SignificanceThe technique provides an early warning of a possible pedicle breakthrough before insertion of the more harmful, larger and threaded screw. 相似文献
25.
张晨 《中华整形外科杂志》2021,(2)
肉毒毒素注射引起的不良反应,是药物本身的组成成分引起的与用药目的无关的有害反应,与医生注射方式和注射技术无关。尽管肉毒毒素生产厂家的药品说明书上也有提示,但其所提供的信息不够全面,也未必能引起医生的足够重视。目前文献上多为散发病例。为此作者对过去20年有关肉毒毒素注射引起的过敏反应、肉瘤样肉芽肿、眼睑水肿、流感样症状等相关不良反应的临床表现、发病机制与治疗方法进行综述。 相似文献
26.
Jae Eun Choi Tyler Werbel Zhenping Wang Chia Chi Wu Tony L. Yaksh Anna Di Nardo 《Journal of dermatological science》2019,93(1):58-64
Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献27.
张景惠 ' target='_blank'> 王丽 ' target='_blank'> 卫浩亮 ' target='_blank'> 李京凯 ' target='_blank'> 张宝来 杨孝来 ' target='_blank'> 《现代肿瘤医学》2022,(22):4182-4187
蛋白质精氨酸甲基转移酶1(protein arginine methyltransferase 1,PRMT1)是主要的Ⅰ型精氨酸甲基转移酶,催化一甲基化和不对称二甲基化,其底物被甲基化后参与细胞生物学过程。研究表明,PRMT1在多种恶性肿瘤中异常表达,促进肿瘤细胞的增殖、侵袭和迁移,调控人类多种肿瘤发生发展过程,揭示PRMT1可能成为肿瘤治疗中潜在的生物标志物或靶点。本文对PRMT1的结构、底物、生物学功能、及其在肿瘤发生发展中的作用进行总结,旨在为今后研究PRMT1相关肿瘤提供参考。 相似文献
28.
欧前胡素是从中药当归中提取的呋喃香豆素类化合物,临床上常用于治疗头痛、炎症、心血管疾病等。近年来研究发现,欧前胡素对多种类型的肿瘤细胞增殖均有抑制作用,能发挥抗肿瘤的功效。本文就欧前胡素对肿瘤及相关疾病的治疗作用和机制进行探讨,以期从不同的角度为肿瘤治疗提供新思路、新方法,并对欧前胡素的进一步研究和开发利用提供理论基础。 相似文献
29.
《Neuromodulation》2021,24(8):1317-1326
ObjectivesHow spinal cord stimulation (SCS) in its different modes suppresses pain is poorly understood. Mechanisms of action may reside locally in the spinal cord, but also involve a larger network including subcortical and cortical brain structures. Tonic, burst, and high-frequency modes of SCS can, in principle, entrain distinct temporal activity patterns in this network, but finally have to yield specific effects on pain suppression. Here, we employ high-density electroencephalography (EEG) and recently developed spatial filtering techniques to reduce SCS artifacts and to enhance EEG signals specifically related to neuromodulation by SCS.Materials and MethodsWe recorded high-density resting-state EEGs in patients suffering from pain of various etiologies under different modes of SCS. We established a pipeline for the robust spectral analysis of oscillatory brain activity during SCS, which includes spatial filtering for attenuation of pulse artifacts and enhancement of brain activity potentially modulated by SCS.ResultsIn sensor regions responsive to SCS, neuromodulation strongly reduced activity in the theta and low alpha range (6–10 Hz) in all SCS modes. Results were consistent in all patients, and in accordance with thalamocortical dysrhythmia hypothesis of pain. Only in the tonic mode showing paresthesia as side effect, SCS also consistently and strongly reduced high-gamma activity (>84 Hz).ConclusionsEEG spectral analysis combined with spatial filtering allows for a spatially and temporally specific assessment of SCS-related, neuromodulatory EEG activity, and may help to disentangle therapeutic and side effects of SCS. 相似文献
30.
降尿酸是治疗痛风和高尿酸血症的基本方法,目前降尿酸作用途径主要是通过抑制黄嘌呤氧化酶、腺苷脱氨酶等合成酶的活性,或(且)影响肾脏尿酸转运蛋白(OAT1、OAT3、URAT1、GLUT9)等的表达,进而降低尿酸的水平。由于中药治疗高尿酸血症及痛风的作用机制尚不明确,因此本文通过检索中国知网、维普、万方、pubMed、Embase等数据库,对相关文献进行筛选,总结了具有明确降尿酸作用机制的单味中药,并进行功效归类,有助于对其作用机制进一步研究,为防治痛风和高尿酸血症提供更可靠、更安全的中医治疗依据。 相似文献